Evidence mapPaperPMID 41964674Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Uncovering potential biomarkers for chronic kidney disease of unknown etiology through a network-based bioinformatic approach.

Aleeta Maria Jolly, Sonu Benny, Aneesh Thankappan Presanna, Rajesh Rajasekharan Nair, Jaya Thomas

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleeta Maria JollyDepartment of Pharmacology, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India.
Sonu BennyDepartment of Pharmaceutical Chemistry, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India.
Aneesh Thankappan PresannaDepartment of Pharmaceutical Chemistry, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India.
Rajesh Rajasekharan NairAmrita Institute of Medical Sciences, Kochi, Kerala, India.
Jaya ThomasDepartment of Pharmacology, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India. jayathomas@pharmacy.aims.amrita.edu.

Funding

Indian Council of Medical Research 2021-8967
6 · The paper itself

Abstract

CKDu is a renal disorder characterized by a decline in eGFR < 60 mL/min/1.73 m

Indexed as

Chronic Kidney Diseases of Uncertain EtiologyComputational BiologyAnimalsBiomarkersHumansBiomarkersBiomarkerCKDuNetwork-based bioinformaticsRenal tubular injury

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.